Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
JYNT Stock Summary
Top 10 Correlated ETFs
JYNT
In the News

The Joint (JYNT) Forays Into West Virginia Chiropractic Market
The Joint's (JYNT) new facility is positioned near the West Virginia University campus, at a high-traffic shopping center.

The Joint (JYNT) Q2 Earnings Miss Estimates, 2023 View Down
The Joint (JYNT) expects to open 100-120 franchised clinics in 2023 compared with 121 opened last year.

The Joint Corp. (JYNT) Reports Q2 Loss, Misses Revenue Estimates
The Joint Corp. (JYNT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.02 per share a year ago.

The Joint Corp. to Participate in Upcoming Conferences
SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management plans to participate in and conduct one-on-one meetings at these upcoming conferences.

The Joint Corp. (JYNT) Q2 2023 Earnings Call Transcript
The Joint Corp. (NASDAQ:JYNT ) Q2 2023 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations Peter Holt - President and Chief Executive Officer Jake Singleton - Chief Financial Officer Conference Call Participants Jeremy Hamblin - Craig-Hallum Capital Group Jeff Van Sinderen - B. Riley Thomas McGovern - Maxim Group George Kelly - ROTH MKM Operator Hello, and welcome to The Joint Corp. Second Quarter 2023 Financial Results Conference Call.

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit
The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year.

The Joint Corp. to Host Conference Call on Thursday, August 10th to Discuss Second Quarter 2023 Results
SCOTTSDALE, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its second quarter 2023 financial results on Thursday, August 10, 2023, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.

The Joint (JYNT) Buys Wisconsin Regional Developer Zone Rights
The Joint (JYNT) expects the Wisconsin region to hold a total of 53 clinics, of which 21 are currently operating.

The Joint Corp. (JYNT) Surges 10.0%: Is This an Indication of Further Gains?
The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

The Joint Corp. to Participate in Upcoming Conferences
SCOTTSDALE, Ariz., May 15, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management plans to participate in and conduct one-on-one meetings at these upcoming conferences.
JYNT Financial details
JYNT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 2.33 | 3.51 | 4.19 | 5.67 | 7.03 | |
Net income per share | 0.02 | 0.24 | 0.94 | 0.5 | 0.08 | |
Operating cash flow per share | 0.4 | 0.54 | 0.8 | 1.06 | 0.77 | |
Free cash flow per share | 0.3 | 0.24 | 0.5 | 0.48 | 0.16 | |
Cash per share | 0.64 | 0.61 | 1.47 | 1.36 | 0.67 | |
Book value per share | 0.17 | 0.41 | 1.48 | 2.06 | 2.23 | |
Tangible book value per share | -0.16 | -0.12 | 0.95 | 1.33 | 0.76 | |
Share holders equity per share | 0.17 | 0.41 | 1.48 | 2.06 | 2.23 | |
Interest debt per share | 0.13 | 1.03 | 1.32 | 1.57 | 1.86 | |
Market cap | 113.73M | 223.04M | 367.74M | 940.64M | 202.55M | |
Enterprise value | 106.11M | 228.86M | 365.66M | 943.57M | 218.86M | |
P/E ratio | 449.37 | 67.11 | 27.93 | 131.39 | 172.05 | |
Price to sales ratio | 3.58 | 4.6 | 6.27 | 11.59 | 1.99 | |
POCF ratio | 20.86 | 29.65 | 32.88 | 61.75 | 18.27 | |
PFCF ratio | 27.99 | 66.44 | 52.63 | 137.23 | 87.66 | |
P/B Ratio | 48.16 | 38.99 | 17.72 | 31.85 | 6.26 | |
PTB ratio | 48.16 | 38.99 | 17.72 | 31.85 | 6.26 | |
EV to sales | 3.34 | 4.72 | 6.23 | 11.62 | 2.15 | |
Enterprise value over EBITDA | 36.7 | 41.44 | 45.01 | 77.59 | 20.76 | |
EV to operating cash flow | 19.46 | 30.43 | 32.7 | 61.94 | 19.74 | |
EV to free cash flow | 26.12 | 68.18 | 52.33 | 137.66 | 94.72 | |
Earnings yield | 0 | 0.01 | 0.04 | 0.01 | 0.01 | |
Free cash flow yield | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | |
Debt to equity | 0.77 | 2.5 | 0.89 | 0.76 | 0.8 | |
Debt to assets | 0.08 | 0.33 | 0.28 | 0.27 | 0.28 | |
Net debt to EBITDA | -2.63 | 1.05 | -0.26 | 0.24 | 1.55 | |
Current ratio | 1.34 | 0.98 | 1.35 | 1.17 | 0.76 | |
Interest coverage | 0 | 0 | 0 | 0 | 3.04 | |
Income quality | 21.54 | 2.26 | 0.85 | 2.13 | 9.42 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0.33 | |
Sales general and administrative to revenue | 0.64 | 0.63 | 0.62 | 0.61 | 0.67 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.19 | 0.17 | 0.11 | 0.12 | 0.23 | |
Capex to operating cash flow | -0.25 | -0.55 | -0.38 | -0.55 | -0.79 | |
Capex to revenue | -0.04 | -0.09 | -0.07 | -0.1 | -0.09 | |
Capex to depreciation | -0.89 | -2.19 | -1.53 | -1.38 | -1.15 | |
Stock based compensation to revenue | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
Graham number | 0.27 | 1.5 | 5.6 | 4.82 | 2.02 | |
ROIC | 0.06 | 0.1 | 0.25 | 0.1 | 0.02 | |
Return on tangible assets | 0.01 | 0.09 | 0.23 | 0.1 | 0.02 | |
Graham Net | -0.81 | -1.95 | -1.6 | -2.22 | -3.17 | |
Working capital | 2.97M | -262.64K | 6.45M | 3.77M | -5.5M | |
Tangible asset value | -2.19M | -1.65M | 13.26M | 19.07M | 11.04M | |
Net current asset value | -9.45M | -24.68M | -19.85M | -27.9M | -41.93M | |
Invested capital | 0.77 | 2.5 | 0.89 | 0.76 | 0.8 | |
Average receivables | 1.34M | 2.07M | 2.31M | 2.62M | 3.65M | |
Average payables | 1.16M | 1.39M | 1.54M | 1.63M | 2.34M | |
Average inventory | 668.51K | 850.26K | 1.06M | 1.27M | 1.62M | |
Days sales outstanding | 15.65 | 20.9 | 11.51 | 15.24 | 14.01 | |
Days payables outstanding | 106.13 | 100.06 | 87.59 | 73.12 | 110.15 | |
Days of inventory on hand | 63.44 | 62.39 | 65.23 | 59.2 | 69.04 | |
Receivables turnover | 23.32 | 17.47 | 31.71 | 23.94 | 26.06 | |
Payables turnover | 3.44 | 3.65 | 4.17 | 4.99 | 3.31 | |
Inventory turnover | 5.75 | 5.85 | 5.6 | 6.17 | 5.29 | |
ROE | 0.11 | 0.58 | 0.63 | 0.24 | 0.04 | |
Capex per share | -0.1 | -0.3 | -0.3 | -0.59 | -0.61 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 1.73 | 1.83 | 1.91 | 1.95 | 2 | |
Net income per share | 0.02 | 0.03 | 0.04 | 0.16 | -0.01 | |
Operating cash flow per share | 0.07 | 0.29 | 0.37 | 0.41 | 0.1 | |
Free cash flow per share | -0.23 | 0.21 | 0.25 | 0.33 | 0 | |
Cash per share | 0.65 | 0.71 | 0.67 | 1.01 | 0.93 | |
Book value per share | 2.1 | 2.17 | 2.23 | 2.41 | 2.42 | |
Tangible book value per share | 0.92 | 0.89 | 0.76 | 1.01 | 1.16 | |
Share holders equity per share | 2.1 | 2.17 | 2.23 | 2.41 | 2.42 | |
Interest debt per share | 1.74 | 1.73 | 1.81 | 1.66 | 1.91 | |
Market cap | 221.62M | 228M | 203.13M | 245.15M | 198.23M | |
Enterprise value | 237.25M | 242.22M | 219.44M | 258.29M | 212.62M | |
P/E ratio | 160.72 | 116.06 | 92.8 | 26.63 | -260.31 | |
Price to sales ratio | 8.84 | 8.57 | 7.3 | 8.62 | 6.76 | |
POCF ratio | 217.86 | 54.06 | 37.6 | 40.69 | 134.99 | |
PFCF ratio | -68.03 | 74.52 | 56.41 | 50.81 | -3.24K | |
P/B Ratio | 7.28 | 7.24 | 6.27 | 6.99 | 5.57 | |
PTB ratio | 7.28 | 7.24 | 6.27 | 6.99 | 5.57 | |
EV to sales | 9.47 | 9.1 | 7.89 | 9.08 | 7.25 | |
Enterprise value over EBITDA | 100.9 | 79.65 | 59.59 | 143.88 | 94.77 | |
EV to operating cash flow | 233.22 | 57.43 | 40.62 | 42.87 | 144.78 | |
EV to free cash flow | -72.83 | 79.17 | 60.94 | 53.54 | -3.48K | |
Earnings yield | 0 | 0 | 0 | 0.01 | 0 | |
Free cash flow yield | -0.01 | 0.01 | 0.02 | 0.02 | 0 | |
Debt to equity | 0.82 | 0.78 | 0.8 | 0.8 | 0.79 | |
Debt to assets | 0.29 | 0.28 | 0.28 | 0.28 | 0.28 | |
Net debt to EBITDA | 6.64 | 4.68 | 4.43 | 7.32 | 6.41 | |
Current ratio | 0.87 | 0.87 | 0.76 | 0.94 | 0.9 | |
Interest coverage | 3.3 | 1.86 | 7.41 | 0.15 | 0 | |
Income quality | 2.95 | 8.59 | 9.87 | 2.62 | -8.89 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0.06 | 0 | |
Sales general and administrative to revenue | 0.66 | 0.67 | 0.66 | 0.7 | 0.68 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.2 | 0.21 | 0.23 | 0.21 | 0.19 | |
Capex to operating cash flow | -4.2 | -0.27 | -0.33 | -0.2 | -1.04 | |
Capex to revenue | -0.17 | -0.04 | -0.06 | -0.04 | -0.05 | |
Capex to depreciation | -2.51 | -0.58 | -0.78 | -0.51 | -0.69 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 1.06 | 1.29 | 1.37 | 2.93 | 0.84 | |
ROIC | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Return on tangible assets | 0 | 0.01 | 0.01 | 0.03 | 0 | |
Graham Net | -2.94 | -2.93 | -3.16 | -3.06 | -3.16 | |
Working capital | -2.53M | -2.72M | -5.5M | -1.41M | -2.41M | |
Tangible asset value | 13.32M | 12.87M | 11.04M | 14.7M | 17.06M | |
Net current asset value | -38.05M | -37.84M | -41.93M | -39.39M | -41.17M | |
Invested capital | 0.82 | 0.78 | 0.8 | 0.8 | 0.79 | |
Average receivables | 3.59M | 3.75M | 3.93M | 3.72M | 3.53M | |
Average payables | 1.72M | 1.78M | 2.47M | 2.4M | 1.71M | |
Average inventory | 1.9M | 2.1M | 1.92M | 1.82M | 1.96M | |
Days sales outstanding | 12.79 | 13.35 | 12.66 | 11.15 | 10.86 | |
Days payables outstanding | 58.29 | 71.64 | 102.69 | 63 | 54.65 | |
Days of inventory on hand | 82.59 | 71.28 | 64.36 | 61.41 | 73.62 | |
Receivables turnover | 7.04 | 6.74 | 7.11 | 8.07 | 8.29 | |
Payables turnover | 1.54 | 1.26 | 0.88 | 1.43 | 1.65 | |
Inventory turnover | 1.09 | 1.26 | 1.4 | 1.47 | 1.22 | |
ROE | 0.01 | 0.02 | 0.02 | 0.07 | -0.01 | |
Capex per share | -0.3 | -0.08 | -0.12 | -0.08 | -0.1 |
JYNT Frequently Asked Questions
What is The Joint Corp. stock symbol ?
The Joint Corp. is a US stock , located in Scottsdale of Az and trading under the symbol JYNT
What is The Joint Corp. stock quote today ?
The Joint Corp. stock price is $9.12 today.
Is The Joint Corp. stock public?
Yes, The Joint Corp. is a publicly traded company.